Which factor should guide dosing adjustments of caffeine citrate in apnea of prematurity?

• A. Age
• B. Diet
• C. Blood type
• D. Renal function

Answer: (D)

In preterm infants with apnea of prematurity, how a drug is cleared from the body determines how we adjust its dose. Caffeine citrate is used to stimulate breathing, and its clearance depends on how well the infant’s kidneys can eliminate caffeine metabolites. Because the kidneys in premature babies are immature and function can vary widely, renal function becomes the most direct guide for adjusting dosing. If kidney function is reduced, clearance slows, the drug stays in the body longer, and side effects can increase. That’s why dosing adjustments rely on renal function—often assessed by urine output and creatinine-based estimates of kidney filtration—to balance achieving the desired respiratory effect with minimizing toxicity. Diet and blood type don’t influence caffeine’s pharmacokinetics, and while age and maturation affect organ function, the clearest, actionable factor for dose adjustment here is renal function.